Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Triazavirin vs Oseltamivir for COVID-19
NCT04973462Phase 4Unknown
- Sponsor
- Ain Shams University
- Start
- Aug 2021
- Primary completion
- Sep 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of favipiravir in coronavirus disease 2019 (COVID-19) (2 arms), sponsored by Ain Shams University. Primary endpoint: Physicians Global Assessment to measure the baseline COVID-19 signs and symptoms. Status: unknown.
02
Drugs
favipiravir
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04973462.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04973462.